These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4643455)

  • 1. The effect of -methyl-p-tyrosine and substantia nigra lesions on spinal motor activity in the rat.
    Jurna I; Ruzdić N; Nell T; Grossmann W
    Eur J Pharmacol; 1972 Dec; 20(3):341-50. PubMed ID: 4643455
    [No Abstract]   [Full Text] [Related]  

  • 2. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 3. Motor disturbance induced by tremorine and oxotremorine.
    Jurna I; Nell T; Schreyer I
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(1):80-98. PubMed ID: 4393397
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
    Jurna I; Theres C; Bachmann T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(3):427-38. PubMed ID: 4239718
    [No Abstract]   [Full Text] [Related]  

  • 5. The dependence of the anti-nociceptive effect of morphine and other analgesic agents on spinal motor activity after central monoamine depletion.
    Grossmann W; Jurna I; Nell T; Theres C
    Eur J Pharmacol; 1973 Oct; 24(1):67-77. PubMed ID: 4756170
    [No Abstract]   [Full Text] [Related]  

  • 6. Abolition of spinal motor disturbance by injections of dopamine receptor agonists, atropin and GABA into the caudate nucleus.
    Jurna I; Brenner M; Drum P
    Neuropharmacology; 1978 Jan; 17(1):35-44. PubMed ID: 652131
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative histochemical studies of striatal dopamine depletion following DL-alpha-methyl-p-tyrosine administration.
    Dowson JH
    Neuropharmacology; 1973 Oct; 12(10):949-53. PubMed ID: 4750563
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of substantia nigra stimulation on suralis-evoked spinal reflex activity: comparison with the effects of morphine and stimulation in the periaqueductal gray matter.
    Blinn G; Heinz G; Jurna I
    Neuropharmacology; 1980 Jan; 19(1):75-85. PubMed ID: 6244511
    [No Abstract]   [Full Text] [Related]  

  • 9. On the mode of action of amantadine.
    Stromberg U; Svensson TH; Waldeck B
    J Pharm Pharmacol; 1970 Dec; 22(12):959-62. PubMed ID: 4395528
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
    Jurna I; Lanzer G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(3):309-24. PubMed ID: 4238719
    [No Abstract]   [Full Text] [Related]  

  • 11. The rotational behavior model: asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats.
    Robinson TE; Becker JB
    Brain Res; 1983 Mar; 264(1):127-31. PubMed ID: 6405975
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.
    Dravid A; Jaton AL; Enz A; Frei P
    Brain Res; 1984 Oct; 311(2):361-5. PubMed ID: 6149789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the amplitude of the startle reflex following lesions of substantia nigra].
    Cebulla M; Klingberg F
    Acta Biol Med Ger; 1971; 26(1):209-11. PubMed ID: 5577791
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of amantadine on motor activity and catalepsy in rats.
    Maj J; Sowińska H; Baran L
    Psychopharmacologia; 1972; 24(2):296-307. PubMed ID: 5064006
    [No Abstract]   [Full Text] [Related]  

  • 15. On the role of ascending catecholaminergic projections in intracranial self-stimulation of the substantia nigra.
    Clavier RM; Fibiger HC
    Brain Res; 1977 Aug; 131(2):271-86. PubMed ID: 890458
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine-independent motor behavior following microinjection of rimorphin in the substantia nigra.
    Matsumoto RR; Lohof AM; Patrick RL; Walker JM
    Brain Res; 1988 Mar; 444(1):67-74. PubMed ID: 2896062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for the stimulation of rat brain dopamine receptors by a cyclic analogue of dopamine.
    Woodruff GN; Elkhawad AO; Crossman AR; Walker RJ
    J Pharm Pharmacol; 1974 Sep; 26(9):740-1. PubMed ID: 4155756
    [No Abstract]   [Full Text] [Related]  

  • 18. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 19. Multisensory control of spinal reflex pathways.
    Lundberg A
    Prog Brain Res; 1979; 50():11-28. PubMed ID: 121776
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.